SINTX Technologies Inc

SINTX Technologies, Inc. engages in the development and commercialization of silicon nitride for medical and non-medical applications. It markets spinal fusion products and develops products for use in total hip and knee joint replacements. The company was founded by Aaron A. Hofmann and Ashok C. Khandkar in 1996 and is headquartered in Salt Lake City, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The stock price of SINTX Technologies Inc (NASDAQ: SINT) has increased by over 47% during intraday trading. This is why it happened.

SINT Stock Price Increased Over 47% Intraday: Why It Happened

----------- Salt Lake City, UT, March 09, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies (www.sintx.com) (“SINTX”; “the Company”) a company that develops and commercializes silicon nitride for multiple applications, today announced test results showing that fabrics containing SINTX's silicon nitride continue to demonstrate inactivation of the SARS-CoV-2 virus upon contact. Earlier tests had shown that sintered silicon nitride powders reduced viral loads by as much as 99.9%, starting at one minute after exposure to silicon nitride.

SINTX Technologies announces a fabric technology shown to inactivate upon contact SARS-CoV-2, the virus causing the COVID-19 pandemic

SALT LAKE CITY, UT, March 03, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) ( www.sintx.com ), an original equipment manufacturer (OEM) of silicon nitride ceramic, announced its FDA submission of a Master Access File (MAF) for a new Silicon Nitride – Polyetheretherketone (PEEK) composite material (SN-PEEK). The MAF can be referenced by SINTX customers toward developing new medical implant designs and products.

SINTX Submits Master Access File to FDA for Silicon Nitride-Polymer Composite Material

SALT LAKE CITY--(BUSINESS WIRE)--O2TODAY ("O2TODAY"), a mask company that develops, manufactures and commercializes face masks for medical and non-medical uses, and SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) (www.sintx.com), an original equipment manufacturer (OEM) of silicon nitride ceramics, announced today they have entered into a worldwide exclusive licensing agreement. O2TODAY expects to release their first consumer mask integrated with SINTX's silicon nitride durin

O2TODAY and SINTX Technologies Enter Commercialization Agreement to Fight COVID-19

SALT LAKE CITY, Jan. 06, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. ( www.sintx.com ) (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of silicon nitride ceramic for medical and non-medical applications, will celebrate its 25th year in existence in 2021. The Company has a successful track record of more than 35,000 spinal implantations and established leadership in the manufacturing and science of silicon nitride. The Company disclosed its three key areas of focus for 2021, which includes antipathogenic applications, industrial applications, and biomedical opportunities for its silicon nitride and its proprietary formulations.

SINTX Technologies Looks Ahead to 2021 Opportunities and Beyond

SALT LAKE CITY, Nov. 16, 2020 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. ( www.sintx.com ) (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of silicon nitride ceramic for medical and non-medical applications, shared details on its Q3 business update and new business opportunities ahead.

SINTX Technologies Shares Q3 Business Update and Identifies Growth Opportunities for 2021

SALT LAKE CITY, UT, Nov. 13, 2020 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) ( www.sintx.com ), an original equipment manufacturer (OEM) of silicon nitride ceramic for medical and non-medical applications, and Iwatani Corporation of America (ICA), a wholly-owned subsidiary of Iwatani Corporation, announced today that they have entered into a joint development agreement.

SINTX Technologies and Iwatani Group Announce Agreement to Develop Antipathogenic Surfaces to Help Prevent Spread of the Common Flu, COVID-19, and Other Viral Diseases

Certification Enables SINTX to Supply Components Directly to the Aviation, Space, and Defense Markets.

SINTX Enters Aerospace and Defense Industries with AS9100D Certification

SALT LAKE CITY, Oct. 28, 2020 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. ( www.sintx.com ) (NASDAQ: SINT) (“SINTX” or the “Company”), a manufacturer of silicon nitride ceramic for medical and non-medical applications, today announced that the United States Patent and Trademark Office has issued US Patent 10,806,831 covering antibacterial biomedical implants and associated materials. This newly issued patent broadly covers a variety of biomedical implants wherein the Company's silicon nitride is applied to improve the antibacterial characteristics of the implant.

SINTX Technologies Announces Grant of New U.S Patent For Antibacterial Applications of Silicon Nitride

SALT LAKE CITY, Oct. 06, 2020 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. ( www.sintx.com ) (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of silicon nitride ceramic for medical and non-medical applications, announced progress toward the manufacture of a “catch-and-kill” mask that will inactivate respiratory viruses. Exposure to silicon nitride has been shown to neutralize several bacterial species and viral strains.

SINTX Technologies Develops New Mask Fabric with Silicon Nitride

SALT LAKE CITY, Oct. 05, 2020 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. ( www.SINTX.com ) (NASDAQ: SINT), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride and its applications, announced today that Michael Marcroft has been appointed Vice President of Business Development. In this role, Mr. Marcroft will lead business development initiatives within the medical device sector.

SINTX TECHNOLOGIES APPOINTS MICHAEL MARCROFT AS VICE PRESIDENT OF BUSINESS DEVELOPMENT

SALT LAKE CITY, UT, Oct. 02, 2020 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride and its applications today announced that it has filed a universal shelf registration statement on Form S-3 with the United States Securities and Exchange Commission (“SEC”). SINTX filed the shelf registration statement with the SEC to provide the Company with flexibility to access the capital markets in the future if circumstances arise that would make the sale of securities advantageous to the Company and its stockholders. The Company has no immediate plans to offer or sell any securities under this shelf registration statement to the public. However, the Company felt it was prudent to file the shelf registration statement as a matter of standard corporate governance in order to respond to future financing and business opportunities.

SINTX Files Universal Shelf Registration on Form S-3

Research targets the development of face masks and other products that inactivate viruses.

SINTX Technologies Announces New Antiviral Test Results

SALT LAKE CITY, UT, Aug.  13, 2020  (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride and its applications, today announced that it has scheduled a conference call to provide a business update to take place on Wednesday, August 19th, 2020, at 3:00 p.m. Eastern Time.

SINTX Technologies to Host Conference Call to Provide Business Update

SALT LAKE CITY, UT , Aug.  10, 2020  (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride and its applications announced the closing of its previously announced registered direct offering of 3,415,000 shares of its common stock at a purchase price of $2.40 per share for gross proceeds of $8.2 million priced at-the-market under Nasdaq rules.

SINTX Technologies Announces Closing of $8.2 Million Registered Direct Offering

SALT LAKE CITY, UT, Aug.  05, 2020  (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride and its applications, today announced that it has entered into a share purchase agreement with several institutional investors for the issuance and sale of 3,415,000 shares of its common stock at a price of $2.40 per share, for aggregate gross proceeds of approximately $8.2 million, in a registered direct offering priced at-the-market under Nasdaq rules. 

SINTX Technologies Announces Pricing of $8.2 Million Registered Direct Offering Priced At-The-Market

SALT LAKE CITY--(BUSINESS WIRE)--O2TODAY (www.O2TODAY.com), an original equipment manufacturer (OEM) company who develops and commercializes face masks for medical and non-medical applications, today announced that it has entered into a joint development agreement with SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX”) (www.sintx.com).

O2TODAY Announces Agreement to Develop Antimicrobial Face Masks with SINTX Technologies, Inc. to Help Prevent Spread of COVID-19 and Other Viral Diseases

SALT LAKE CITY, UT, Aug.  04, 2020  (GLOBE NEWSWIRE) -- O2TODAY ( www.O2TODAY.com ), an original equipment manufacturer (OEM) company who develops and commercializes face masks for medical and non-medical applications, today announced that it has entered into a joint development agreement with SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX”) ( www.sintx.com  ). The goal of this agreement is to develop a safe and effective consumer facemask with broad-spectrum antibacterial and antiviral activity, based on incorporating SINTX’s unique silicon nitride powder into the mask filter and fabric. The successful development of such a product may help prevent the spread of respiratory diseases by catching and inactivating SARS-CoV-2 and other viruses and bacteria in the mask itself before they can enter into the human body.

O2TODAY ANNOUNCES AGREEMENT TO DEVELOP ANTIMICROBIAL FACE MASKS WITH SINTX TECHNOLOGIES INC. TO HELP PREVENT SPREAD OF COVID-19 AND OTHER VIRAL DISEASES

SINTX Technologies (NASDAQ: SINT) shares are trading higher on Thursday after the company announced on Twitter that the company completed its AS9100D stage audit II.

Why SINTX Technologies Is Trading Higher Today

SALT LAKE CITY, UT, July  22, 2020  (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride and its applications announced the closing of its previously announced registered direct offering of 1,500,000 shares of its common stock at a purchase price of $2.00 per share for gross proceeds of $3,000,000 priced at-the-market under Nasdaq rules.

SINTX Technologies Announces Closing of $3 Million Registered Direct Offering

SALT LAKE CITY, UT, July  17, 2020  (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride and its applications, today announced that it has entered into a share purchase agreement with several institutional investors for the issuance and sale of 1,500,000 shares of its common stock at a price of $2.00 per share, for aggregate gross proceeds of approximately $3.0 million, in a registered direct offering priced at-the-market under Nasdaq rules.

SINTX Technologies Announces Pricing of $3.0 Million Registered Direct Offering Priced At-The-Market

SALT LAKE CITY, UT, July  14, 2020  (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride and its applications is pleased to announce that it has received a letter from the NASDAQ Listing Qualifications Staff notifying the Company that it has regained compliance with NASDAQ's minimum bid price requirements for continued listing on the Nasdaq Capital Market. The letter noted that as a result of the closing bid price of the Company's common stock having been at $1.00 per share or greater for at least ten consecutive business days, from June 22, 2020 to July 8, 2020, the Company has regained compliance with Listing Rule 5550(a)(2) and the matter is now closed.

SINTX Technologies Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement

Evoke Pharma

Francesca's Holdings

Neonode

Last Friday was my 56th consecutive green day of trading and I ended up ending it with a gross profit of $225,000, which easily blows past the $1 million mark for the streak and is several magnitudes better than the profits from the streak it replaces.

The End Of A Record Green Streak, The Beginning Of Something New

SALT LAKE CITY, UT, June  26, 2020  (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride and its applications, today announced that it has entered into a share purchase agreement with several institutional investors for the issuance and sale of 2,400,000 shares of its common stock at a price of $1.72 per share, for aggregate gross proceeds of approximately $4.1 million, in a registered direct offering priced at-the-market under Nasdaq rules.

SINTX Technologies Announces Pricing of $4.1 Million Registered Direct Offering Priced At-The-Market

SALT LAKE CITY--(BUSINESS WIRE)--SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride and its applications, today announced positive testing results demonstrating the anti-viral properties of its silicon nitride which may be useful in the reduction of the spread of COVID-19. The study results demonstrated that SINTX’s unique grade of silicon nitride inactivates the SARS-CoV-2 virus within a minut

News for SINTX Technologies Inc Stock (SINT)